Correlation Between Salesforce and Mydecine Innovations

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salesforce and Mydecine Innovations at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Mydecine Innovations into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Mydecine Innovations Group, you can compare the effects of market volatilities on Salesforce and Mydecine Innovations and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Mydecine Innovations. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Mydecine Innovations.

Diversification Opportunities for Salesforce and Mydecine Innovations

-0.21
  Correlation Coefficient

Very good diversification

The 3 months correlation between Salesforce and Mydecine is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Mydecine Innovations Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mydecine Innovations and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Mydecine Innovations. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mydecine Innovations has no effect on the direction of Salesforce i.e., Salesforce and Mydecine Innovations go up and down completely randomly.

Pair Corralation between Salesforce and Mydecine Innovations

Considering the 90-day investment horizon Salesforce is expected to generate 34.49 times less return on investment than Mydecine Innovations. But when comparing it to its historical volatility, Salesforce is 11.36 times less risky than Mydecine Innovations. It trades about 0.03 of its potential returns per unit of risk. Mydecine Innovations Group is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  0.50  in Mydecine Innovations Group on September 24, 2024 and sell it today you would lose (0.10) from holding Mydecine Innovations Group or give up 20.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Salesforce  vs.  Mydecine Innovations Group

 Performance 
       Timeline  
Salesforce 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.
Mydecine Innovations 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.

Salesforce and Mydecine Innovations Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salesforce and Mydecine Innovations

The main advantage of trading using opposite Salesforce and Mydecine Innovations positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Mydecine Innovations can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mydecine Innovations will offset losses from the drop in Mydecine Innovations' long position.
The idea behind Salesforce and Mydecine Innovations Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals